Role of phytochemicals in the modulation of miRNA expression in cancer

Trishna Debnath1, Narayan Chandra Deb Nath, Eun-Kyung Kim

  • 1Department of Food Science and Biotechnology, Dongguk University-Seoul, 32 Dongguk-ro, Ilsandong-gu, Goyang, Korea. kwglee@dongguk.edu.

Food & Function
|August 8, 2017
PubMed

Insights

MicroRNAs (miRNAs) regulate cancer development and metastasis. Phytochemicals modulate miRNA expression, offering potential to suppress tumors, prevent metastasis, and enhance drug sensitivity in cancer therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are crucial non-coding RNAs involved in normal physiological processes.
  • Dysregulated miRNAs are implicated in cancer initiation, progression, metastasis, and epithelial-to-mesenchymal transition (EMT).

Purpose of the Study:

  • To review the roles of tumor-suppressing and oncogenic miRNAs in cancer.
  • To explore the mechanisms of miRNA action in cancer.
  • To discuss the impact of phytochemicals on miRNA expression and their therapeutic potential in cancer.

Main Methods:

  • Literature review of studies on miRNAs, cancer, EMT, and phytochemicals.
  • Analysis of miRNA functions (oncogenic vs. tumor-suppressing).
  • Examination of phytochemicals' influence on miRNA expression patterns.

Main Results:

  • miRNAs are key regulators in cancer development, progression, and metastasis.
  • Phytochemicals can modulate miRNA expression, affecting oncogenes, tumor suppressors, and cancer-related proteins.
  • Modulation of miRNAs by phytochemicals shows potential in suppressing tumors, preventing metastasis, reversing EMT, and improving drug sensitivity.

Conclusions:

  • Phytochemicals represent a promising avenue for cancer therapy through miRNA modulation.
  • Targeting miRNA pathways with phytonutrients could offer novel strategies for cancer treatment.
  • Further research into phytochemical-miRNA interactions is warranted for clinical applications.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K